Get the Stockscreener App
2.42
3.20%
-0.08
After Hours:
2.42
Anebulo Pharmaceuticals Inc stock is traded at $2.42, with a volume of 63,856.
It is down -3.20% in the last 24 hours and up +4.76% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
See More
Previous Close:
$2.50
Open:
$2.4501
24h Volume:
63,856
Relative Volume:
0.90
Market Cap:
$99.43M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-8.0667
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
-8.33%
1M Performance:
+4.76%
6M Performance:
+126.17%
1Y Performance:
+64.61%
1-Day Range:
$2.33
$2.497
1-Week Range:
$2.33
$2.65
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.42 | 102.71M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
How Anebulo Pharmaceuticals Inc. stock valuations compare to rivalsTrade Risk Summary & Weekly High Potential Stock Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Closing Moves & Free Community Supported Trade Ideas - newser.com
Top chart patterns to watch in Anebulo Pharmaceuticals Inc.July 2025 Retail & Safe Capital Preservation Plans - newser.com
Anebulo Pharmaceuticals Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Risk vs reward if holding onto Anebulo Pharmaceuticals Inc.Take Profit & Low Risk Entry Point Tips - newser.com
Custom watchlist performance reports with Anebulo Pharmaceuticals Inc.July 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com
Quantitative breakdown of Anebulo Pharmaceuticals Inc. recent move2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Has Anebulo Pharmaceuticals Inc. found a price floor2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Will earnings trigger a reversal in Anebulo Pharmaceuticals Inc.Trade Risk Report & Expert Approved Momentum Trade Ideas - newser.com
Multi factor analysis applied to Anebulo Pharmaceuticals Inc.Market Performance Summary & Accurate Trade Setup Notifications - newser.com
Will Anebulo Pharmaceuticals Inc. stock beat EPS estimatesJuly 2025 Decliners & Capital Efficient Trade Techniques - newser.com
Risk Report: Can Anebulo Pharmaceuticals Inc. stock rebound after recent weaknessMarket Growth Report & Consistent Income Trade Ideas - fcp.pa.gov.br
How Anebulo Pharmaceuticals Inc. stock reacts to global recession fearsTrade Signal Summary & Free Community Supported Trade Ideas - newser.com
Is Anebulo Pharmaceuticals Inc. stock a buy for dividend growthJuly 2025 Outlook & Daily Chart Pattern Signals - newser.com
Can Anebulo Pharmaceuticals Inc. stock double in next 5 years2025 Market WrapUp & High Accuracy Swing Entry Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock attractive for ETFsWeekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Is it too late to sell Anebulo Pharmaceuticals Inc.Trade Exit Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will Anebulo Pharmaceuticals Inc. continue its uptrendGap Up & Weekly Momentum Stock Picks - newser.com
Is Anebulo Pharmaceuticals Inc. stock resilient to inflationQuarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
Price action breakdown for Anebulo Pharmaceuticals Inc.Quarterly Trade Summary & Community Consensus Trade Alerts - newser.com
What Wall Street predicts for Anebulo Pharmaceuticals Inc. stock priceJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
What is the fair value of Anebulo Pharmaceuticals Inc. stock now2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - newser.com
Advanced analytics toolkit walkthrough for Anebulo Pharmaceuticals Inc.July 2025 Market Mood & Fast Exit Strategy with Risk Control - newser.com
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):